PKI-166

Code: SML1095-25MG D2-231

Biochem/physiol Actions

PKI-166 is a potent, selective and orally available EGF-R tyrosine kinase inhibitor. PKI-166 potently inhibits the growth and metastasis of many human...


read more

Your Price
€524.85 25MG
€645.57 inc. VAT
REQUEST

Biochem/physiol Actions

PKI-166 is a potent, selective and orally available EGF-R tyrosine kinase inhibitor. PKI-166 potently inhibits the growth and metastasis of many human cancers including human pancreatic cancer.

Other Notes

Light and air sensitive.

Packaging

5, 25 mg in glass bottle

assay≥98% (HPLC)
colorwhite to beige
formpowder
Gene Informationhuman ... EGFR(1956)
InChI keyXRYJULCDUUATMC-CYBMUJFWSA-N
InChI1S/C20H18N4O/c1-13(14-5-3-2-4-6-14)23-19-17-11-18(24-20(17)22-12-21-19)15-7-9-16(25)10-8-15/h2-13,25H,1H3,(H2,21,22,23,24)/t13-/m1/s1
Quality Level100
SMILES stringOC(C=C1)=CC=C1C2=CC3=C(N2)N=CN=C3N[C@H](C)C4=CC=CC=C4
solubilityDMSO: 10 mg/mL, clear
storage temp.2-8°C
Cas Number187724-61-4
Hazard Class6.1
Un Number2811
Pack GroupIII
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.